Back

Watch Compare

agilon health, inc.

Data quality: 100%

AGL

NYSE Services Health Services

$19.83

▲ $1.36 (7.36%)

Mkt Cap: 329.30 M

Price

$19.83

Mkt Cap

329.30 M

Day Range

$16.54 — $19.91

52-Week Range

$7.48 — $144.25

Volume

330,969

Open $18.38

50D / 200D Avg

$14.04

41.20% above

50D / 200D Avg

$25.62

22.59% below

Quick Summary

Key Takeaways

Revenue grew 34.12% annually over 5 years — strong growth

Debt/Equity of 0.00 — conservative balance sheet

Negative free cash flow of -119.01 M

Revenue growth is decelerating — 1Y growth trails 5Y average by 36.23%

Capital efficient — spends only 0.22% of revenue on capex

Growth

Revenue Growth (5Y)

34.12%

Above sector avg (19.14%)

Revenue (1Y)-2.11%

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Quality

Return on Equity

-109.47%

Below sector avg (-1.53%)

ROIC-89.24%

Net Margin-6.60%

Op. Margin-7.81%

Safety

Debt / Equity

0.00

Below sector avg (1.02)

Current Ratio1.08

Interest Coverage-69.75

Valuation

PE (TTM)

-0.84

Below sector avg (-0.01)

P/B Ratio1.08

EV/EBITDAN/A

Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (20 peers)

Metric	Stock	Sector Median
P/E	-0.8	0.0
P/B	1.1	3.1
ROE %	-109.5	-1.5
Net Margin %	-6.6	-0.3
Rev Growth 5Y %	34.1	19.1
D/E	0.0	1.0

ETFs Holding This Stock

NIXT Research Affiliates Deletions ETF

0.57% weight

DEEF Xtrackers FTSE Developed ex US Multifactor ETF

0.28% weight

VIDI Vident International Equity Strategy ETF

0.27% weight

FLAU Franklin FTSE Australia ETF

0.25% weight

PINK Simplify Health Care ETF

0.18% weight

DIM WisdomTree International MidCap Dividend Fund

0.17% weight

FDT First Trust Developed Markets ex-US AlphaDEX Fund

0.09% weight

AVSC Avantis U.S. Small Cap Equity ETF

0.07% weight

BKIE BNY Mellon International Equity ETF

0.02% weight

GXUS Goldman Sachs MarketBeta Total International Equity ETF

0.01% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y)	-2.11%	Revenue Growth (3Y)	17.24%
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	34.12%	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	5.93 B	Net Income (TTM)	-391.35 M
ROE	-109.47%	ROA	-23.65%
Gross Margin	N/A	Operating Margin	-7.81%
Net Margin	-6.60%	Free Cash Flow (TTM)	-119.01 M
ROIC	-89.24%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	0.00	Current Ratio	1.08
Interest Coverage	-69.75	Asset Turnover	3.59
Working Capital	98.15 M	Tangible Book Value	206.69 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-0.84	Forward P/E	N/A
P/B Ratio	1.08	P/S Ratio	0.06
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-36.14%
Market Cap	329.30 M	Enterprise Value	157.62 M
Per Share
EPS (Diluted TTM)	N/A	Revenue / Share	357.25
FCF / Share	-7.17	OCF / Share	-6.37
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	0.22%	FCF Conversion	30.41%
SBC-Adj. FCF	-171.86 M	Growth Momentum	-36.23

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	5.93 B	6.06 B	4.32 B	2.71 B	1.83 B
Net Income	-391.35 M	-260.15 M	-262.60 M	-106.55 M	-406.49 M
EPS (Diluted)	—	—	—	—	—
Gross Profit	—	—	—	—	—
Operating Income	-463.24 M	-292.13 M	-232.13 M	-120.43 M	-393.95 M
EBITDA	—	—	—	—	—
R&D Expenses	—	—	—	—	—
SG&A Expenses	—	—	—	—	—
D&A	28.59 M	24.46 M	20.16 M	13.77 M	14.67 M
Interest Expense	6.64 M	6.18 M	6.66 M	4.53 M	6.15 M
Income Tax	1.25 M	1.45 M	791,000.0	1.64 M	886,000.0

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	1.27 B	1.73 B	1.74 B	1.70 B	1.59 B
Total Liabilities	1.14 B	1.26 B	1.08 B	656.86 M	494.66 M
Shareholders' Equity	126.73 M	470.95 M	661.84 M	1.04 B	1.09 B
Total Debt	34.99 M	34.90 M	38.56 M	43.75 M	48.75 M
Cash & Equivalents	173.71 M	188.23 M	107.57 M	497.07 M	1.04 B
Current Assets	1.10 B	1.46 B	1.48 B	1.45 B	1.37 B
Current Liabilities	1.08 B	1.15 B	977.16 M	535.09 M	356.96 M